HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$3.74
Day range
$3.35 - $4.28
Year range
$2.96 - $11.45
Market cap
44.60M USD
Avg Volume
49.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.24M | 31.21% |
Net income | -11.83M | -47.30% |
Net profit margin | — | — |
Earnings per share | -1.15 | — |
EBITDA | -10.16M | -32.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.85M | 38.28% |
Total assets | 24.48M | -3.91% |
Total liabilities | 19.61M | -19.27% |
Total equity | 4.87M | — |
Shares outstanding | 10.26M | — |
Price to book | 7.79 | — |
Return on assets | -99.18% | — |
Return on capital | -171.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.83M | -47.30% |
Cash from operations | -12.12M | -48.94% |
Cash from investing | 3.00K | 117.65% |
Cash from financing | 11.02M | 9.80% |
Net change in cash | -1.10M | -158.12% |
Free cash flow | -8.42M | -82.11% |
About
Founded
2011
Headquarters
Website
Employees
32